Search for: "UP-262 - State v. Williams" Results 61 - 66 of 66
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
23 Dec 2019, 1:19 pm by David Kris
Fourth, what is to be made of statements by Attorney General William Barr and U.S. [read post]
9 Jun 2023, 9:07 am by Bill Marler
State laboratories can send STEC cultures to the CDC to determine the serotype. [read post]
23 Sep 2023, 7:21 pm by Bill Marler
State laboratories can send STEC cultures to the CDC to determine the serotype. [read post]
30 Apr 2024, 3:12 pm by Bill Marler
”[58] Other long-term problems include the risk for hypertension, proteinuria (abnormal amounts of protein in the urine that can portend a decline in renal function), and reduced kidney filtration rate.[59] Since the longest available follow-up studies of HUS victims are 25 years, an accurate lifetime prognosis is not readily available and remains controversial.[60] All that can be said for certain is that HUS causes permanent injury, including loss of kidney function,… [read post]
8 Jun 2024, 5:20 pm by Bill Marler
”[58] Other long-term problems include the risk for hypertension, proteinuria (abnormal amounts of protein in the urine that can portend a decline in renal function), and reduced kidney filtration rate.[59] Since the longest available follow-up studies of HUS victims are 25 years, an accurate lifetime prognosis is not readily available and remains controversial.[60] All that can be said for certain is that HUS causes permanent injury, including loss of kidney function,… [read post]
13 Apr 2024, 3:33 pm by admin
Prelude to Litigation Phenylpropanolamine (PPA) was a widely used direct α-adrenergic agonist used as a medication to control cold symptoms and to suppress appetite for weight loss.[1] In 1972, an over-the-counter (OTC) Advisory Review Panel considered the safety and efficacy of PPA-containing nasal decongestant medications, leading, in 1976, to a recommendation that the agency label these medications as “generally recognized as safe and effective. [read post]